ArticleBMC oral health2025
Quorum quenching by Est816: a novel approach to control Porphyromonas gingivalis pathogenicity.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- [Research Progress on Quorum Sensing-Regulated Oral Microbial Interaction Networks in Periodontitis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026Review
- N-Frontiers in oral health · 2026Article
- Quorum sensing in oral multispecies biofilms: from interkingdom communication to therapeutic targeting.Frontiers in microbiology · 2026Review
- Nano-enabled disruption of bacterial virulence and communication in plant pathosystems: emerging strategies for sustainable disease management.Frontiers in plant science · 2026Review
- Nanozymes for periodontal biofilm-associated challenges: mechanisms, platforms, and translational perspectives.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPorphyromonas gingivalis (P. gingivalis), a keystone pathogen in peri-implantitis, employs quorum sensing (QS) via N-acyl homoserine lactones (AHLs) to regulate biofilm formation and virulence. Quorum-quenching enzymes, such as the AHL-lactonase Est816, offer a promising therapeutic strategy to disrupt microbial pathogenicity. This study investigated the anti-biofilm, anti-virulence, immunomodulatory, biocompatibility, and osteogenic properties of Est816 against P. gingivalis, exploring its therapeutic potential for peri-implantitis management.
methodsP. gingivalis (ATCC 33277) was cultured on titanium discs and treated with Est816 (P. gingivalis + Est816). Biofilm morphology, biomass, viability, and kinetics were assessed using scanning electron microscopy (SEM), crystal violet staining, confocal laser scanning microscope (CLSM), and colony-forming unit (CFU) counting. Exopolysaccharide (EPS) production was quantified via phenol-sulfuric acid assay, while virulence gene expression was analyzed by RT-PCR. Cytotoxicity of Est816 on human oral keratinocytes (HOKs) was assessed using immunofluorescent microscopy. The immunodulatory impact of Est816 on P. gingivalis infected human periodontal ligament stem cells (PDLSCs) was assessed via ELISA and RT-PCR. Osteogenic differentiation of PDLSCs was examined by alizarin red staining.
resultsEst816 treatment disrupted biofilm architecture (SEM), reducing biomass (crystal violet: 88% decrease, p < 0.001), viability (CLSM: live/dead ratio 0.3 vs. 5.7 control, p < 0.05), and CFU counts (2.8-log reduction, p < 0.001). EPS production decreased by 44% (p < 0.01), and virulence gene expression was significantly suppressed (rgpA: 80%, kgp: 76%, fimA: 73%, p < 0.01). Est816 exhibited no cytotoxicity toward HOKs and attenuated pro-inflammatory cytokine secretion in PDLSCs (TNF-α: 2.4-fold, IL-1β: 2.3-fold, IL-6: 11-fold, IL-8: 14-fold, reduction, p < 0.05). Furthermore, Est816 alone had no effect on the osteogenic differentiation of PDLSCs; however, it abolished the inhibitory effect of AHLs, significantly enhancing mineralized nodule formation by 1.4-fold (p < 0.001) compared to the AHL-treated control.
conclusionEst816 exhibited anti-biofilm property, attenuated virulence release in P. gingivalis, and counteracted AHL-mediated suppression of osteoblast differentiation in PDLSCs, highlighting its dual therapeutic role in both pathogen inhibition and host tissue regeneration for peri-implantitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.